Literature DB >> 8448281

Treatment of opportunistic fungal infections.

D Armstrong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8448281     DOI： 10.1093/clinids/16.1.1

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  13 in total

1.  Right ear pain and neck swelling.

Authors:  H Kirkpatrick; R E Jones; V Wadlington; J M Gilsoul
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-04

2.  Persistent pulmonary lesion in a patient with rheumatoid arthritis.

Authors:  F Buttgereit; K Künzel; H J Tietz; K Sajkiewicz; K Gellert; F Hiepe; G R Burmester
Journal:  Ann Rheum Dis       Date:  1994-12       Impact factor: 19.103

3.  Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

Authors:  M A Pfaller; Q Vu; M Lancaster; A Espinel-Ingroff; A Fothergill; C Grant; M R McGinnis; L Pasarell; M G Rinaldi; L Steele-Moore
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

4.  Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis.

Authors:  R Santangelo; P Paderu; G Delmas; Z W Chen; R Mannino; L Zarif; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Molecular evaluation of the plasma membrane proton pump from Aspergillus fumigatus.

Authors:  Henriette P Burghoorn; Patricia Soteropoulos; Padmaja Paderu; Ryota Kashiwazaki; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  Aspergillus pneumonia successfully treated with itraconazole in a patient with systemic lupus erythematosus.

Authors:  J Collazos; E Martínez; M Flores; J Mayo
Journal:  Clin Investig       Date:  1994-11

7.  Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.

Authors:  M A Pfaller; M Bale; B Buschelman; M Lancaster; A Espinel-Ingroff; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

8.  Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.

Authors:  G F Behre; S Schwartz; K Lenz; W D Ludwig; H Wandt; E Schilling; V Heinemann; H Link; A Trittin; O Boenisch
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

9.  Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

Authors:  A M Sugar; C A Hitchcock; P F Troke; M Picard
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Authors:  Lynn Purkins; Nolan Wood; Katie Greenhalgh; Michael J Allen; Stuart D Oliver
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.